Le M. Pham
Gyeongsan-si, 712749, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Corrigendum to "Hyaluronic acid wreathed, trio-stimuli receptive and on-demand triggerable nanoconstruct for anchored combinatorial cancer therapy" [Carbohydrate Polymers 249 (2020) 116815].
Journal: Carbohydrate polymers
Published: September 19, 2025
Nanoparticle-based methionine and AICAR delivery elicits a robust antitumor immune response.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 21, 2025
Preparation and evaluation of dabrafenib-loaded, CD47-conjugated human serum albumin-based nanoconstructs for chemoimmunomodulation.
Journal: Colloids and surfaces. B, Biointerfaces
Published: June 24, 2021
Combination chemotherapeutic and immune-therapeutic anticancer approach via anti-PD-L1 antibody conjugated albumin nanoparticles.
Journal: International journal of pharmaceutics
Published: April 21, 2021
Redox/photo dual-responsive, self-targeted, and photosensitizer-laden bismuth sulfide nanourchins for combination therapy in cancer.
Journal: Nanoscale
Published: January 06, 2021
Hyaluronic acid wreathed, trio-stimuli receptive and on-demand triggerable nanoconstruct for anchored combinatorial cancer therapy.
Journal: Carbohydrate polymers
Published: April 23, 2020
Manipulating immune system using nanoparticles for an effective cancer treatment: Combination of targeted therapy and checkpoint blockage miRNA.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 09, 2020
Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 10, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026